Could just be MM driving price down to pick up shares at a bargain before moving back higher as next catalyst nears such as possibility of Mabthera CHMP approval in a couple weeks, or just happens such as new partnership announcement.
...when Opko presents for investors at the Oppenheimer 24th Annual Healthcare Conference on Tuesday, December 10, 2013 at 10:55 AM (ET).
yes, good, since not obvious with spammer going wild today. Probably a good sign of positive things to come soon though.
RXi Pharmaceuticals Corporation and Ethicor Ltd Announce the Signing of a Distribution Agreement for RXI-109 in the European Union (see RXi pharma web site).
Plus RXII presents at Piper Jaffray conference tomorrow at noon.
I think we may be seeing what could also be interpreted as a slow motion short squeeze, since investors and funds see the terrific value here hence so few sellers, yet short interest is right near high and as of last update on 11/15 was at 12.7M shares. Being short has to be unsettling with current big positive catalysts looming, possibly 3 this month alone.
Nice find Wilder.
Not surprisingly, 91.5% of patients preferred Herceptin SC (5 minutes) over Herceptin via IV (30-90 minutes), 1.7% had no preference. Bodes well for higher royalty revenues from Roche.
The only thing that has changed except for news of George Soros buying, 4Kscore study now underway (which is basically also a subtle but smart ad campaign), Rayaldy study enrollment complete, and all other development timelines moving forward?
They bought close to $2B previous quarter. A very good sign.
Thnks for the reply gophread, but I meant "conferences" like Credit Suisse, not "conference calls".
Question for Fezz (or anyone): Did Baxter announce the HyQ FDA filing at a conference last time, or simply via stand-alone press release?
Question for Fezz (or anyone): Does Baxter usually announce such things at conferences? Did they last time they filed? Or is it normally by a press release?
By 2pm (4.5hours), more than double average daily volume (which is also more than twice the number of shares being offered) has traded at a rough average of $65. A good sign.
Not so sure he will get "ripped". Pacific Crest Securities raised their target today from $48 up to $75 (source: flyonthewall).